Gertsch; Jurg Patent Filings

Patent	Date
Substituted 2-imino-1,3-thiazolidin-4-ones as N-arachidonoylethanolamine cellular uptake inhibitors Grant 10,774,077 - Reymond , et al. Sept	2020-09-15
Thiazolidinone Compounds And Their Use In The Treatment Of Psychiatric Or Neurological Disorders And Inflammation, In Particular App 20190382397 - REYMOND; Jean-Louis ; et al.	2019-12-19
Inhibitor of endocannabinoid cellular reuptake Grant 10,414,721 - Chicca , et al. Sept	2019-09-17
Substituted 2-imino-1,3-thiazolidin-4-ones as N-arachidonoylethanolamine cellular uptake inhibitors Grant 10,392,377 - Reymond , et al. A	2019-08-27
Thiazolidinones as cellular anandamide uptake inhibitors and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation Grant 10,300,048 - Reymond , et al.	2019-05-28
Thiazolidinone Compounds And Their Use In The Treatment Of Psychiatric Or Neurological Disorders And Inflammation, In Particular Neuroinflammation App 20190119265 - REYMOND; Jean-Louis ; et al.	2019-04-25
Substituted 2-imino-1,3-thiazolidin-4-ones as N-arachidonoylethanolamine cellular uptake inhibitors Grant 10,155,754 - Reymond , et al. Dec	2018-12-18
Thiazolidinones As Cellular Anandamide Uptake Inhibitors And Their Use In The Treatment Of Psychiatric Or Neurological Disorders And Inflammation, In Particular Neuroinflammation App 20170296515 - REYMOND; Jean-Louis ; et al.	2017-10-19
Thiazolidinone Compounds And Their Use In The Treatment Of Psychiatric Or Neurological Disorders And Inflammation, In Particular Neuroinflammation App 20170197952 - REYMOND; Jean-Louis ; et al.	2017-07-13

Patent

Date

Substituted 2-imino-1,3-thiazolidin-4-ones as N-arachidonoylethanolamine cellular uptake inhibitors
Grant 10,774,077 - Reymond , et al. Sept

2020-09-15

Thiazolidinone Compounds And Their Use In The Treatment Of Psychiatric Or Neurological Disorders And Inflammation, In Particular
App 20190382397 - REYMOND; Jean-Louis ; et al.

2019-12-19

Inhibitor of endocannabinoid cellular reuptake
Grant 10,414,721 - Chicca , et al. Sept

2019-09-17

Substituted 2-imino-1,3-thiazolidin-4-ones as N-arachidonoylethanolamine cellular uptake inhibitors
Grant 10,392,377 - Reymond , et al. A

2019-08-27

Thiazolidinones as cellular anandamide uptake inhibitors and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation
Grant 10,300,048 - Reymond , et al.

2019-05-28

Thiazolidinone Compounds And Their Use In The Treatment Of Psychiatric Or Neurological Disorders And Inflammation, In Particular Neuroinflammation
App 20190119265 - REYMOND; Jean-Louis ; et al.

2019-04-25

Substituted 2-imino-1,3-thiazolidin-4-ones as N-arachidonoylethanolamine cellular uptake inhibitors
Grant 10,155,754 - Reymond , et al. Dec

2018-12-18

Thiazolidinones As Cellular Anandamide Uptake Inhibitors And Their Use In The Treatment Of Psychiatric Or Neurological Disorders And Inflammation, In Particular Neuroinflammation
App 20170296515 - REYMOND; Jean-Louis ; et al.

2017-10-19

Thiazolidinone Compounds And Their Use In The Treatment Of Psychiatric Or Neurological Disorders And Inflammation, In Particular Neuroinflammation
App 20170197952 - REYMOND; Jean-Louis ; et al.

2017-07-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

Gertsch; Jurg

Patent Applications and Registrations